Home/ Stocks/ NVCT

Nuvectis Pharma, Inc. Common Stock

NVCT XNAS

$19.52 +1.62 (+8.81%) ▲ 15-min delayed

Open

$18.61

High

$20.26

Low

$18.42

Volume

899.3K

Market Cap

$487.80M

About Nuvectis Pharma, Inc. Common Stock

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-6,050,000	$-0.26
FY 2025	N/A	$-26,442,000	$-1.32
Q3 2025	N/A	$-7,462,000	$-0.44
Q2 2025	N/A	$-6,334,000	$-0.30

TickerDaily Coverage

Why Is Nuvectis Pharma, Inc. Common Stock (NVCT) Stock Down 31.2% Today?

Market News Alex Chen · 1d ago

Nuvectis Pharma stock tanked 31.2% Tuesday after the oncology-focused biotech announced pricing for...

View All Coverage →

Get NVCT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Nuvectis Pharma, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.